Navamedic ASA: Broad launch for Eroxon® in Sweden today

Publisert: 06.05.2024

Navamedic ASA: Annual Report 2023

Publisert: 30.04.2024

Navamedic Q1 2024: Successful product launch and steady operational progress

Publisert: 30.04.2024

Navamedic ASA: Invitation to 2024 1st quarter presentation

Publisert: 23.04.2024

Navamedic welcomes new shareholders

Publisert: 13.03.2024

Navamedic Q4 and full year 2023: A year marked by new records and transformative growth initiatives

Publisert: 15.02.2024